Pfizer (NYSE: PFE) awards CEO Albert Bourla 22 phantom stock units

Q: What insider transaction did Pfizer (PFE) report for Albert Bourla on this Form 4?

Albert Bourla received an award of 22 Phantom Stock Units SSP tied to Pfizer common stock. These units are part of his deferred compensation and are settled in cash rather than shares under a company plan.

Q: How many Phantom Stock Units does Albert Bourla hold at Pfizer (PFE) after this transaction?

After the reported award, Albert Bourla holds a total of 785,060 Phantom Stock Units . This figure reflects his cumulative phantom unit balance within Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan as of the transaction date.

Q: How and when will Albert Bourla’s Phantom Stock Units at Pfizer (PFE) be settled?

The Phantom Stock Units are settled in cash after Albert Bourla’s separation from service with Pfizer. Under the plan terms, he can also transfer the units into an alternative investment account at any time before settlement.

Q: Are Albert Bourla’s Phantom Stock Units at Pfizer (PFE) actual shares of common stock?

They are not actual shares ; each Phantom Stock Unit represents one phantom share of common stock. The units track Pfizer’s stock value but ultimately provide a cash payout rather than delivering Pfizer shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

BOURLA ALBERT reported acquisition or exercise transactions in this Form 4 filing.

PFIZER INC (PFE) reported that Chairman & CEO Albert Bourla received an award of 22 Phantom Stock Units SSP on 2026-08-14. Each unit represents one phantom share of common stock and is valued at $26.79 per unit. Following this grant, Bourla holds 785,060 Phantom Stock Units, which are cash-settled under Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan after his separation from service and may be reallocated into alternative investment accounts.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BOURLA ALBERT

Role Chairman & CEO

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units SSP ^{F1, F2}	22	$26.79	$589.38

Holdings After Transaction: Phantom Stock Units SSP — 785,060 shares (Direct)

Footnotes (2)

F1. Each unit represents one phantom share of common stock.
F2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Key Figures

Phantom Stock Units granted: 22 units Reference value per unit: $26.79 per unit Total Phantom Stock Units after transaction: 785,060 units

3 metrics

Phantom Stock Units granted 22 units Grant of Phantom Stock Units SSP on 2026-08-14 to Albert Bourla

Reference value per unit $26.79 per unit Transaction price per Phantom Stock Unit for the 2026-08-14 award

Total Phantom Stock Units after transaction 785,060 units Albert Bourla’s Phantom Stock Unit holdings following the reported grant

Key Terms

Phantom Stock Units, Nonfunded Deferred Compensation and Supplemental Savings Plan, separation from service

3 terms

Phantom Stock Units financial

"Each unit represents one phantom share of common stock."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Nonfunded Deferred Compensation and Supplemental Savings Plan financial

"acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan"

separation from service financial

"are settled in cash following the reporting person's separation from service"

FAQ

What insider transaction did Pfizer (PFE) report for Albert Bourla on this Form 4?

Albert Bourla received an award of 22 Phantom Stock Units SSP tied to Pfizer common stock. These units are part of his deferred compensation and are settled in cash rather than shares under a company plan.

How many Phantom Stock Units does Albert Bourla hold at Pfizer (PFE) after this transaction?

After the reported award, Albert Bourla holds a total of 785,060 Phantom Stock Units. This figure reflects his cumulative phantom unit balance within Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan as of the transaction date.

What is the reference value of the Phantom Stock Units granted to Albert Bourla at Pfizer (PFE)?

The 22 Phantom Stock Units granted to Albert Bourla are valued at $26.79 per unit. Each unit tracks the value of one Pfizer common share but will be settled in cash rather than stock upon payout.

How and when will Albert Bourla’s Phantom Stock Units at Pfizer (PFE) be settled?

The Phantom Stock Units are settled in cash after Albert Bourla’s separation from service with Pfizer. Under the plan terms, he can also transfer the units into an alternative investment account at any time before settlement.

Are Albert Bourla’s Phantom Stock Units at Pfizer (PFE) actual shares of common stock?

They are not actual shares; each Phantom Stock Unit represents one phantom share of common stock. The units track Pfizer’s stock value but ultimately provide a cash payout rather than delivering Pfizer shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 06:15 PM Accepted by SEC EDGAR 08/17/2026 - 06:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOURLA ALBERT

(Last)

(First)

(Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK

10001-2192

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Phantom Stock Units SSP	⁽¹⁾	08/14/2026		A		22		⁽²⁾	⁽²⁾	Common Stock	22	$26.79	785,060	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

	/s/ Shanice A. Reid, by power of atty., for Albert Bourla	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR